Carolina Eye Offers Groundbreaking Program for Advanced Age-related Macular Degeneration

November 11th, 2015 by Carolina Eye Associates

Imagine the heartbreak for someone who gradually loses the ability to see her grandchildren, husband and the people who mean the most to her. Now imagine her joy when she can see them again. Carolina Eye Associates now offers a groundbreaking new treatment program called CentraSight®, for patients with end-stage age related macular degeneration (AMD).

Macular degeneration attacks the macula of the eye, where one’s sharpest central vision occurs. Although it does not cause complete blindness, patients with end-stage AMD have a central blind spot, or missing area, in their vision. This vision loss makes it difficult or impossible to see faces, read, and perform everyday activities such as watching TV, preparing meals, and self-care.

To treat the disease, a tiny telescope is implanted inside the eye. Smaller than a pea, the telescope implant uses micro-optical technology to magnify objects that would normally be seen in one’s ‘straight ahead’ vision. This image is projected onto the healthy retina in the back of the eye not affected by the disease.

The telescope implant improves patients’ vision so they can see the things that are important to them, increase their independence, and manage everyday activities again.

The treatment program focuses on comprehensive patient care, requiring potential patients to undergo medical and vision evaluation to determine whether they may be a good candidate.  A unique aspect of the evaluation is the ability to simulate, prior to surgery, what a person may expect to see once the telescope is implanted to determine if the improvement possible will meet the patient’s expectations. After an eye surgeon implants the telescope in an outpatient procedure, the patient then works with vision specialists to learn how to use their new vision in their everyday activities.

The telescope implant is not a cure. Patients must meet age and cornea health requirements to be considered a good candidate. Possible side effects include decreased vision or vision impairing corneal swelling.

For more information on the CentraSight program at Carolina Eye Associates contact Lisa Fulghum at (910) 295-2100 or toll-free at (800) 733-5357, ext. 881.



Comments are closed.

North Carolina WordPress web design and WordPress web hosting by ConnectNC, Inc.